Literature DB >> 9300481

Crystal structures of bovine chymotrypsin and trypsin complexed to the inhibitor domain of Alzheimer's amyloid beta-protein precursor (APPI) and basic pancreatic trypsin inhibitor (BPTI): engineering of inhibitors with altered specificities.

A J Scheidig1, T R Hynes, L A Pelletier, J A Wells, A A Kossiakoff.   

Abstract

The crystal structures of the inhibitor domain of Alzheimer's amyloid beta-protein precursor (APPI) complexed to bovine chymotrypsin (C-APPI) and trypsin (T-APPI) and basic pancreatic trypsin inhibitor (BPTI) bound to chymotrypsin (C-BPTI) have been solved and analyzed at 2.1 A, 1.8 A, and 2.6 A resolution, respectively. APPI and BPTI belong to the Kunitz family of inhibitors, which is characterized by a distinctive tertiary fold with three conserved disulfide bonds. At the specificity-determining site of these inhibitors (P1), residue 15(I)4 is an arginine in APPI and a lysine in BPTI, residue types that are counter to the chymotryptic hydrophobic specificity. In the chymotrypsin complexes, the Arg and Lys P1 side chains of the inhibitors adopt conformations that bend away from the bottom of the binding pocket to interact productively with elements of the binding pocket other than those observed for specificity-matched P1 side chains. The stereochemistry of the nucleophilic hydroxyl of Ser 195 in chymotrypsin relative to the scissile P1 bond of the inhibitors is identical to that observed for these groups in the trypsin-APPI complex, where Arg 15(I) is an optimal side chain for tryptic specificity. To further evaluate the diversity of sequences that can be accommodated by one of these inhibitors, APPI, we used phage display to randomly mutate residues 11, 13, 15, 17, and 19, which are major binding determinants. Inhibitors variants were selected that bound to either trypsin or chymotrypsin. As expected, trypsin specificity was principally directed by having a basic side chain at P1 (position 15); however, the P1 residues that were selected for chymotrypsin binding were His and Asn, rather than the expected large hydrophobic types. This can be rationalized by modeling these hydrophilic side chains to have similar H-bonding interactions to those observed in the structures of the described complexes. The specificity, or lack thereof, for the other individual subsites is discussed in the context of the "allowed" residues determined from a phage display mutagenesis selection experiment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9300481      PMCID: PMC2143802          DOI: 10.1002/pro.5560060902

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  45 in total

1.  Specificity of alpha-chymotrypsin. Dipeptide substrates.

Authors:  W K. Baumann; S A. Bizzozero; H Dutler
Journal:  FEBS Lett       Date:  1970-06-27       Impact factor: 4.124

2.  On the computation of the fast rotation function.

Authors:  J Navaza
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1993-11-01

3.  Directed evolution of a protein: selection of potent neutrophil elastase inhibitors displayed on M13 fusion phage.

Authors:  B L Roberts; W Markland; A C Ley; R B Kent; D W White; S K Guterman; R C Ladner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

4.  The refined crystal structure of bovine beta-trypsin at 1.8 A resolution. I. Crystallization, data collection and application of patterson search technique.

Authors:  H Fehlhammer; W Bode
Journal:  J Mol Biol       Date:  1975-11-15       Impact factor: 5.469

5.  Structural and functional integrity of specificity and catalytic sites of trypsin.

Authors:  L Gráf; G Hegyi; I Likó; J Hepp; K Medzihradszky; C S Craik; W J Rutter
Journal:  Int J Pept Protein Res       Date:  1988-12

6.  Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity.

Authors:  N Kitaguchi; Y Takahashi; Y Tokushima; S Shiojiri; H Ito
Journal:  Nature       Date:  1988-02-11       Impact factor: 49.962

7.  Converting trypsin to chymotrypsin: residue 172 is a substrate specificity determinant.

Authors:  L Hedstrom; J J Perona; W J Rutter
Journal:  Biochemistry       Date:  1994-07-26       Impact factor: 3.162

8.  On the size of the active site in proteases. I. Papain.

Authors:  I Schechter; A Berger
Journal:  Biochem Biophys Res Commun       Date:  1967-04-20       Impact factor: 3.575

9.  X-ray crystal structure of the protease inhibitor domain of Alzheimer's amyloid beta-protein precursor.

Authors:  T R Hynes; M Randal; L A Kennedy; C Eigenbrot; A A Kossiakoff
Journal:  Biochemistry       Date:  1990-10-30       Impact factor: 3.162

10.  Ecotin is a potent anticoagulant and reversible tight-binding inhibitor of factor Xa.

Authors:  J L Seymour; R N Lindquist; M S Dennis; B Moffat; D Yansura; D Reilly; M E Wessinger; R A Lazarus
Journal:  Biochemistry       Date:  1994-04-05       Impact factor: 3.162

View more
  36 in total

Review 1.  Protein recognition using synthetic surface-targeted agents.

Authors:  Rishi Jain; Justin T Ernst; Olaf Kutzki; Hyung Soon Park; Andrew D Hamilton
Journal:  Mol Divers       Date:  2004       Impact factor: 2.943

2.  Molecular basis for the resistance of an insect chymotrypsin to a potato type II proteinase inhibitor.

Authors:  K M Dunse; Q Kaas; R F Guarino; P A Barton; D J Craik; M A Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-09       Impact factor: 11.205

3.  Computational alanine scanning with linear scaling semiempirical quantum mechanical methods.

Authors:  David J Diller; Christine Humblet; Xiaohua Zhang; Lance M Westerhoff
Journal:  Proteins       Date:  2010-08-01

4.  Mechanisms and specificity of factor XIa and trypsin inhibition by protease nexin 2 and basic pancreatic trypsin inhibitor.

Authors:  Duraiswamy Navaneetham; Dipali Sinha; Peter N Walsh
Journal:  J Biochem       Date:  2010-07-20       Impact factor: 3.387

5.  Weak conservation of structural features in the interfaces of homologous transient protein-protein complexes.

Authors:  Govindarajan Sudha; Prashant Singh; Lakshmipuram S Swapna; Narayanaswamy Srinivasan
Journal:  Protein Sci       Date:  2015-09-08       Impact factor: 6.725

6.  Three-dimensional Structure of a Kunitz-type Inhibitor in Complex with an Elastase-like Enzyme.

Authors:  Rossana García-Fernández; Markus Perbandt; Dirk Rehders; Patrick Ziegelmüller; Nicolas Piganeau; Ulrich Hahn; Christian Betzel; María de Los Ángeles Chávez; Lars Redecke
Journal:  J Biol Chem       Date:  2015-04-15       Impact factor: 5.157

7.  Insights into the serine protease mechanism from atomic resolution structures of trypsin reaction intermediates.

Authors:  Evette S Radisky; Justin M Lee; Chia-Jung Karen Lu; Daniel E Koshland
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

8.  Analgesic compound from sea anemone Heteractis crispa is the first polypeptide inhibitor of vanilloid receptor 1 (TRPV1).

Authors:  Yaroslav A Andreev; Sergey A Kozlov; Sergey G Koshelev; Ekaterina A Ivanova; Margarita M Monastyrnaya; Emma P Kozlovskaya; Eugene V Grishin
Journal:  J Biol Chem       Date:  2008-06-25       Impact factor: 5.157

9.  Structure of an Fab-protease complex reveals a highly specific non-canonical mechanism of inhibition.

Authors:  Christopher J Farady; Pascal F Egea; Eric L Schneider; Molly R Darragh; Charles S Craik
Journal:  J Mol Biol       Date:  2008-05-11       Impact factor: 5.469

10.  The amyloid precursor protein/protease nexin 2 Kunitz inhibitor domain is a highly specific substrate of mesotrypsin.

Authors:  Moh'd A Salameh; Jessica L Robinson; Duraiswamy Navaneetham; Dipali Sinha; Benjamin J Madden; Peter N Walsh; Evette S Radisky
Journal:  J Biol Chem       Date:  2009-11-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.